Literature DB >> 1393687

Immunotherapy with sensitized lymphocytes.

A E Chang1, S Shu.   

Abstract

Mesh：

Year:  1992        PMID： 1393687     DOI： 10.3109/07357909209024795

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  4 in total

1.  Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

Authors:  F P Holladay; T Heitz-Turner; W L Bayer; G W Wood
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

2.  Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2.

Authors:  J R Sporn; M T Ergin; G R Robbins; R G Cable; H Silver; B Mukherji
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

3.  Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells.

Authors:  L Kiremidjian-Schumacher; M Roy; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1994 Apr-May       Impact factor: 3.738

4.  Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.

Authors:  D Moritz; W Wels; J Mattern; B Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.